iShares Biotechnology ETF – NASDAQ:IBB
iShares Biotechnology ETF stock price today
$137.32
+3.79
+2.85%
Market open
Closed in about 5 hours
iShares Biotechnology ETF stock price monthly change
-7.94%
month
iShares Biotechnology ETF stock price quarterly change
-7.94%
quarter
iShares Biotechnology ETF stock price yearly change
-2.44%
year
iShares Biotechnology ETF key metrics
Market Cap | 9.21B |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | 0.15 |
Revenue | 6.79M |
EBITDA | 94.12M |
Income | 46.84M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | 1386.16% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeiShares Biotechnology ETF stock price history
iShares Biotechnology ETF stock forecast
iShares Biotechnology ETF financial statements
| Mar 2010 | 3.4M | 155.51M | 4573.82% |
|---|---|---|---|
| Sep 2011 | 3.39M | -108.67M | -3205.6% |
| Mar 2010 | 1822400000 | 208.3M | 11.43% |
|---|---|---|---|
| Sep 2011 | 1435900000 | 213.3M | 14.85% |
| Mar 2010 | 155.5M | 0 | -168.6M |
|---|---|---|---|
| Sep 2011 | -108.7M | 0 | -146.1M |
iShares Biotechnology ETF other data
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
Top 5 Commercial Biotech Buyout Candidates: Day One Biopharmaceuticals (No. 5)
Duvakitug And Teva's Growth: A Game Changer In Pharma
Biotech Stocks 2024 Second Half Outlook - Buy Biotechs
Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
How To Pick Top Pharma Stocks: Novo Nordisk And More
For Biotech Stocks To Move Higher, This Must Move Lower
Week In Review: China Biopharmas Book $9B In Deals During JP Morgan Conference Week
Horiba: Wonderful Japanese Company At A Very Attractive Price
-
What's the price of iShares Biotechnology ETF stock today?
One share of iShares Biotechnology ETF stock can currently be purchased for approximately $137.32.
-
When is iShares Biotechnology ETF's next earnings date?
Unfortunately, iShares Biotechnology ETF's (IBB) next earnings date is currently unknown.
-
Does iShares Biotechnology ETF pay dividends?
Yes, iShares Biotechnology ETF pays dividends and its trailing 12-month yield is 0.27% with 0% payout ratio. The last iShares Biotechnology ETF stock dividend of $0.04 was paid on 17 Dec 2021.
-
How much money does iShares Biotechnology ETF make?
iShares Biotechnology ETF has a market capitalization of 9.21B.
-
What is iShares Biotechnology ETF's stock symbol?
iShares Biotechnology ETF is traded on the NASDAQ under the ticker symbol "IBB".
-
What is iShares Biotechnology ETF's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of iShares Biotechnology ETF?
Shares of iShares Biotechnology ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When iShares Biotechnology ETF went public?
iShares Biotechnology ETF is publicly traded company for more then 24 years since IPO on 12 Feb 2001.
iShares Biotechnology ETF company profile:
Exchange:
NASDAQ
Full time employees:
0
Industry:
Asset Management
Sector:
Financial Services
The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
San Francisco,
CIK: 0001100663
ISIN: US4642875565
CUSIP: 464287556
